Efficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: protocol for a single-centre, randomised, double-blind, placebo-controlled trial—the ‘DEXAPAE’ study

Efficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: protocol for a single-centre, randomised, double-blind, placebo-controlled trial—the ‘DEXAPAE’ study

Guardado en:
Detalles Bibliográficos
Autores principales: Lars Lonn, Hein Vincent Stroomberg, Klaus Brasso, Martin Andreas Roder, Petra Svarc, Ruben Juhl Jensen, Susanne Frevert, Mats Håkan Lindh, Mikkel Taudorf
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2021
Materias:
Medicine
R
Acceso en línea:https://doaj.org/article/06ccd25cc848479dbc95ac5ecc82bc6b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:06ccd25cc848479dbc95ac5ecc82bc6b
record_format dspace
spelling oai:doaj.org-article:06ccd25cc848479dbc95ac5ecc82bc6b2021-12-04T22:30:05ZEfficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: protocol for a single-centre, randomised, double-blind, placebo-controlled trial—the ‘DEXAPAE’ study10.1136/bmjopen-2020-0478782044-6055https://doaj.org/article/06ccd25cc848479dbc95ac5ecc82bc6b2021-11-01T00:00:00Zhttps://bmjopen.bmj.com/content/11/11/e047878.fullhttps://doaj.org/toc/2044-6055Lars LonnHein Vincent StroombergKlaus BrassoMartin Andreas RoderPetra SvarcRuben Juhl JensenSusanne FrevertMats Håkan LindhMikkel TaudorfBMJ Publishing GrouparticleMedicineRENBMJ Open, Vol 11, Iss 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
Lars Lonn
Hein Vincent Stroomberg
Klaus Brasso
Martin Andreas Roder
Petra Svarc
Ruben Juhl Jensen
Susanne Frevert
Mats Håkan Lindh
Mikkel Taudorf
Efficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: protocol for a single-centre, randomised, double-blind, placebo-controlled trial—the ‘DEXAPAE’ study
format article
author Lars Lonn
Hein Vincent Stroomberg
Klaus Brasso
Martin Andreas Roder
Petra Svarc
Ruben Juhl Jensen
Susanne Frevert
Mats Håkan Lindh
Mikkel Taudorf
author_facet Lars Lonn
Hein Vincent Stroomberg
Klaus Brasso
Martin Andreas Roder
Petra Svarc
Ruben Juhl Jensen
Susanne Frevert
Mats Håkan Lindh
Mikkel Taudorf
author_sort Lars Lonn
title Efficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: protocol for a single-centre, randomised, double-blind, placebo-controlled trial—the ‘DEXAPAE’ study
title_short Efficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: protocol for a single-centre, randomised, double-blind, placebo-controlled trial—the ‘DEXAPAE’ study
title_full Efficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: protocol for a single-centre, randomised, double-blind, placebo-controlled trial—the ‘DEXAPAE’ study
title_fullStr Efficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: protocol for a single-centre, randomised, double-blind, placebo-controlled trial—the ‘DEXAPAE’ study
title_full_unstemmed Efficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: protocol for a single-centre, randomised, double-blind, placebo-controlled trial—the ‘DEXAPAE’ study
title_sort efficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: protocol for a single-centre, randomised, double-blind, placebo-controlled trial—the ‘dexapae’ study
publisher BMJ Publishing Group
publishDate 2021
url https://doaj.org/article/06ccd25cc848479dbc95ac5ecc82bc6b
work_keys_str_mv AT larslonn efficacyofdexamethasoneinreducingthepostembolisationsyndromeinmenundergoingprostaticarteryembolisationforbenignprostatichyperplasiaprotocolforasinglecentrerandomiseddoubleblindplacebocontrolledtrialthedexapaestudy
AT heinvincentstroomberg efficacyofdexamethasoneinreducingthepostembolisationsyndromeinmenundergoingprostaticarteryembolisationforbenignprostatichyperplasiaprotocolforasinglecentrerandomiseddoubleblindplacebocontrolledtrialthedexapaestudy
AT klausbrasso efficacyofdexamethasoneinreducingthepostembolisationsyndromeinmenundergoingprostaticarteryembolisationforbenignprostatichyperplasiaprotocolforasinglecentrerandomiseddoubleblindplacebocontrolledtrialthedexapaestudy
AT martinandreasroder efficacyofdexamethasoneinreducingthepostembolisationsyndromeinmenundergoingprostaticarteryembolisationforbenignprostatichyperplasiaprotocolforasinglecentrerandomiseddoubleblindplacebocontrolledtrialthedexapaestudy
AT petrasvarc efficacyofdexamethasoneinreducingthepostembolisationsyndromeinmenundergoingprostaticarteryembolisationforbenignprostatichyperplasiaprotocolforasinglecentrerandomiseddoubleblindplacebocontrolledtrialthedexapaestudy
AT rubenjuhljensen efficacyofdexamethasoneinreducingthepostembolisationsyndromeinmenundergoingprostaticarteryembolisationforbenignprostatichyperplasiaprotocolforasinglecentrerandomiseddoubleblindplacebocontrolledtrialthedexapaestudy
AT susannefrevert efficacyofdexamethasoneinreducingthepostembolisationsyndromeinmenundergoingprostaticarteryembolisationforbenignprostatichyperplasiaprotocolforasinglecentrerandomiseddoubleblindplacebocontrolledtrialthedexapaestudy
AT matshakanlindh efficacyofdexamethasoneinreducingthepostembolisationsyndromeinmenundergoingprostaticarteryembolisationforbenignprostatichyperplasiaprotocolforasinglecentrerandomiseddoubleblindplacebocontrolledtrialthedexapaestudy
AT mikkeltaudorf efficacyofdexamethasoneinreducingthepostembolisationsyndromeinmenundergoingprostaticarteryembolisationforbenignprostatichyperplasiaprotocolforasinglecentrerandomiseddoubleblindplacebocontrolledtrialthedexapaestudy
_version_ 1718372595966935040

Ejemplares similares